Disseminated Stenotrophomonas maltophilia skin infection
Journal of the European Academy of Dermatology and Venereology · 2023
DOI: 10.1111/jdv.18902 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von Lingzhi Zhong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Stenotrophomonas maltophilia, Skin Diseases, Infectious. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
A 41-year-old woman presented to the dermatology clinic with a 3-month history of painful skin lesions on the extremities. She suffered from membranous nephropathy syndrome and had been taking prednisone for 3 years. Three months ago, she developed painful skin lesions on her right leg. The lesions increased in number and spread to upper and lower extremities gradually. She had no fever or other systemic symptoms. Upon physical examination, multiple papules and nodules with central erosion and crusts were found on her legs and forearms. Lesions on the right leg were numerous and some coalesced to plaques (Figure 1a). A skin biopsy was taken on her right leg, and the histopathology revealed mixed inflammatory infiltrates composed of neutrophils, lymphocytes, histiocytes and multinucleated giant cells in dermis (Figure 1b). Tissue culture on blood agar media grew Stenotrophomonas maltophilia (Figure 1c), which is identified by the VITEK 2 Compact system. In vitro susceptibility testing showed that the isolates were sensitive to trimethoprim-sulfamethoxazole (TMP-SMZ), levofloxacin and minocycline. The lesions completely dissolved after 1-week intravenous ceftriaxone and 1-month oral TMP-SMZ and clarithromycin. No recurrence was found during 4-month follow-up period. Stenotrophomonas maltophilia is a Gram-negative bacillus and a multidrug-resistant opportunistic pathogen. It usually causes infections in immunocompromised individuals, presenting as bacteremia, endocarditis or respiratory tract infections with high mortality rate. Risk factors include use of broad-spectrum antibiotics (especially carbapenems), prolonged hospitalization, presence of central venous line, hematologic malignancies, chemotherapy and severe neutropenia.1 Cutaneous infections of S. maltophilia are rare and have diverse manifestations including primary cellulitis, metastatic cellulitis, subcutaneous nodules, ecthyma gangrenosum and mucocutaneous ulcers.2 The diagnosis depends on tissue culture or blood culture. In our case, the patient had been taking prednisone for a long period and developed a disseminated S. maltophilia skin infection, suggesting that the patient was in immunosuppressive status. The skin lesions are disseminated and present as painful papules and plaques with central erosion and crusts, which differs from the literature report. Stenotrophomonas maltophilia infections are difficult to treat because of their extensive resistance to antibacterial treatments, such as beta-lactams and aminoglycosides. The first-line treatment is high-dose TMP-SMZ. Alternative antibiotics, including ticarcillin-clavulanate, ceftazidime, fluoroquinolones, minocycline, tigecycline and chloramphenicol, have been used in combination with each other or TMP–SMX with varying results.3 Some authors prefer combination regimens for the treatment of severe S. maltophilia infection, particularly in individuals immunocompromised. The efficacy of combination therapy remains unclear and needs clinical evaluation. In this case, the combination therapy of ceftriaxone, TMP-SMZ and clarithromycin successfully resolved the disease. In summary, this case suggests that S. maltophilia infection should be considered if disseminated skin lesions occur in immunocompromised individuals. Timely skin biopsy, tissue culture and appropriate antibacterial treatments are of great importance for successful treatment. None. None. The patient in this manuscript has given written informed consent to the publication of her case details. Data are available on request from the authors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Peking University People's Hospital, Beijing, China.
ORCID-Profile: Lingzhi Zhong
Zitieren
APA
Zhong, L., Li, H., & Zhang, J. (2023). Disseminated Stenotrophomonas maltophilia skin infection. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.18902
Vancouver
Zhong L, Li H, Zhang J. Disseminated Stenotrophomonas maltophilia skin infection. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.18902
BibTeX
@article{Zhong2023,
author = {Zhong, Lingzhi and Li, Houmin and Zhang, Jianzhong},
title = {Disseminated Stenotrophomonas maltophilia skin infection},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2023},
doi = {10.1111/jdv.18902}
}
EUVIMED